REVIEW PAPER
The changing role of ultrasonography examination in patients with rheumatoid arthritis in light of recent studies
More details
Hide details
1
Department of Radiology and Imaging Diagnostics, Dr Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland
2
Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland
3
Department of Rheumatology and Connective Tissue Diseases, Dr Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland
4
Non-public Health Care Centre “Nasz Lekarz”, Toruń, Poland
Submission date: 2020-03-29
Final revision date: 2020-04-15
Acceptance date: 2020-06-02
Online publication date: 2020-06-29
Publication date: 2020-06-29
Reumatologia 2020;58(3):155-161
KEYWORDS
TOPICS
ABSTRACT
For many years, ultrasonography (US) has been a widely accepted modality used for joint assessment in patients with rheumatoid arthritis (RA). Given the efficacy of present day therapies, there is scepticism whether it is required in the first place. The most recent clinical Targeting synovitis in Early Rheumatoid Arthritis (TaSER) and Clinical Tight Control Therapy (ARCTIC) trials’ results appear to contradict it, yet this does not necessarily mean ultrasound has no place in modern rheumatology. The possibility of detecting inflammation at a subclinical level carries a tremendous predictive value, enabling identification of patients likely to experience an exacerbation in the coming months. Therefore, US should be a part of the decision-making process regarding treatment modification or introduction of any additional interventions, such as glucocorticosteroid injections. The results of the most recent clinical trials do not negate the usefulness of US, but merely suggest that it ought to be used in moderation.
REFERENCES (43)
1.
do Prado AD, Staub HL, Bisi MC, et al. Ultrasound and its clinical use in rheumatoid arthritis: where do we stand? Adv Rheumatol 2018; 58: 19.
2.
Grassi W, De Angelis R, Lamanna G, Cervini C. The clinical features of rheumatoid arthritis. Eur J Radiol 1998; 27 (Suppl 1): 18-24, DOI: 10.1016/s0720-048x(98)00038-2.
3.
Heidari B. Rheumatoid arthritis: early diagnosis and treatment outcomes. Caspian J Intern Med 2011; 2: 161-170.
4.
Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet 2017; 389: 2338-2348, DOI: 10.1016/S0140-6736(17)31491-5.
5.
Migliore A, Bizzi E, Petrella L, et al. The challenge of treating early-stage rheumatoid arthritis: the contribution of mixed treatment comparison to choosing appropriate biologic agents. BioDrugs 2016; 30: 105-115, DOI: 10.1007/s40259-016-0164-7.
6.
Jeka S, Dura M, Zuchowski P, et al. The role of ultrasonography in the diagnostic criteria for rheumatoid arthritis and monitoring its therapeutic efficacy. Adv Clin Exp Med 2018; 27: 1303-1307, DOI: 10.17219/acem/69133.
7.
Naredo E, Wakefield RJ, Iagnocco A, et al. The OMERACT ultrasound task force-status and perspectives. J Rheumatol 2011; 38: 2063-2067, DOI: 10.3899/jrheum.110425.
8.
D’Agostino MA, Terslev L, Aegerter P, et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce – part 1: definition and development of a standardised, consensus-based scoring system. RMD Open 2017; 3: e000428, DOI: 10.1136/rmdopen-2016-000428.
9.
Terslev L, Christensen R, Aga AB, et al. Assessing synovitis in the hands in patients with rheumatoid arthritis by ultrasound: an agreement study exploring the most inflammatory active side from two Norwegian trials. Arthritis Res Ther 2019; 21: 166, DOI: 10.1186/s13075-019-1930-y.
10.
Haavardsholm EA, Aga AB, Olsen IC, et al. Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial. BMJ 2016; 354: i4205, DOI: 10.1136/bmj.i4205.
11.
Dale J, Stirling A, Zhang R, et al. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial. Ann Rheum Dis 2016; 75: 1043-1050, DOI: 10.1136/annrheumdis-2015-208941.
12.
Caporali R, Smolen JS. Back to the future: forget ultrasound and focus on clinical assessment in rheumatoid arthritis management. Ann Rheum Dis 2018; 77: 18-20, DOI: 10.1136/annrheumdis-2017-211458.
13.
Schwartz DT. Counter-Point: are we really ordering too many CT scans? West J Emerg Med 2008; 9: 120-122.
14.
Gadeholt O. Forward to the past: ultrasound might be necessary in some patients with rheumatoid arthritis. Ann Rheum Dis 2019; 78: e56, DOI: 10.1136/annrheumdis-2018-213278.
15.
Cerqueira M, Teixeira F, Sousa Neves J, et al. Relationship between clinical evaluation and ultrasound assessment of rheumatoid arthritis patients using a 12 joint score. Int J Rheum Dis 2013; 20: 852-858, DOI: 10.1111/1756-185X.13005.
16.
Chakr RM, Mendonça JA, Brenol CV, et al. Assessing rheumatoid arthritis disease activity with ultrasound. Clin Rheumatol 2013; 32: 1249-1254, DOI: 10.1007/s10067-013-2291-6.
17.
Terslev L, Naredo E, Aegerter P, et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce – part 2: reliability and application to multiple joints of a standardised consensus-based scoring system. RMD Open 2017; 3: e000427, DOI: 10.1136/rmdopen-2016-000427.
18.
D’Agostino MA, Terslev L, Wakefield R, et al. Novel algorithms for the pragmatic use of ultrasound in the management of patients with rheumatoid arthritis: from diagnosis to remission. Ann Rheum Dis 2016; 75: 1902-1908, DOI: 10.1136/annrheumdis-2016-209646.
19.
Grassi W, Gaywood I, Pande I, et al. From DAS 28 to SAS 1. Clin Exp Rheumatol 2012; 30: 649–651.
20.
Yoshimi R, Ihata A, Kunishita Y, et al. A novel 8-joint ultrasound score is useful in daily practice for rheumatoid arthritis. Mod Rheumatol 2014; 25: 379-385, DOI: 10.3109/14397595.2014.974305.
21.
Szkudlarek M, Terslev L, Wakefield RJ, et al. Summary findings of a systematic literature review of the ultrasound assessment of bone erosions in rheumatoid arthritis. J Rheumatol 2016; 43: 12-21, DOI: 10.3899/jrheum.141416.
22.
Sudoł-Szopińska I, Jans L, Teh J. Rheumatoid arthritis: what do MRI and ultrasound show. J Ultrason 2017; 17: 5-16, DOI: 10.15557/JoU.2017.0001.
23.
Ohrndorf S, Boer AC, Boeters DM, et al. Do musculoskeletal ultrasound and magnetic resonance imaging identify synovitis and tenosynovitis at the same joints and tendons? A comparative study in early inflammatory arthritis and clinically suspect arthralgia. Arthritis Res Ther 2019; 21: 59, DOI: 10.1186/s13075-019-1824-z.
24.
Huajun X, Yingchun Z, Huimei Z, et al. Comparison of the clinical effectiveness of US grading scoring system vs MRI in the diagnosis of early rheumatoid arthritis (RA). J Orthop Surg Res 2017; 12: 152, DOI: 10.1186/s13018-017-0653-5.
25.
Tan YK, Østergaard M, Conaghan PG. Imaging tools in rheumatoid arthritis: ultrasound vs magnetic resonance imaging. Rheumatology (Oxford) 2012; 51 (Suppl 7): vii36-42, DOI: 10.1093/rheumatology/kes329.
26.
Cingoz M, Kandemirli SG, Alis DC, et al. Evaluation of median nerve by shear wave elastography and diffusion tensor imaging in carpal tunnel syndrome. Eur J Radiol 2018; 101: 59-64, DOI: 10.1016/j.ejrad.2018.02.005.
27.
Barczyńska TA, Dura M, Blumfield E, et al. DAS28 score vs. ultrasound examination for assessment of rheumatoid arthritis disease activity: comparison and discussion of pros and cons. Reumatologia 2015; 53: 213-218, DOI: 10.5114/reum.2015.53999.
28.
Padovano I, Costantino F, Breban M, et al. Prevalence of ultrasound synovial inflammatory findings in healthy subjects. Ann Rheum Dis 2016; 75: 1819-1823, DOI: 10.1136/annrheumdis-2015-208103.
29.
Yu X, Li Z, Ren M, et al. Superb microvascular imaging (SMI) for evaluating hand joint lesions in patients with rheumatoid arthritis in clinical remission. Rheumatol Int 2018; 38: 1885-1890, DOI: 10.1007/s00296-018-4112-3.
30.
D’Agostino MA, Boers M, Wakefield RJ, et al. Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting abatacept: results from the APPRAISE study. RMD Open 2016; 5: e000237, DOI: 10.1136/rmdopen-2015-000237.
31.
Gärtner M, Mandl P, Radner H, et al. Sonographic joint assessment in rheumatoid arthritis: associations with clinical joint assessment during a state of remission. Arthritis Rheum 2013; 65: 2005-2014, DOI: 10.1002/art.38016.
32.
Olmez MO, Gunal EK, Ureyen SB, et al. Comparison of composite indices with global synovitis score on ultrasound for detecting remission. Clin Rheumatol 2017; 37: 1111-4, DOI: 10.1007/s10067-017-3925-x.
33.
Jeka S, Dura M, Żuchowski P, et al. The role of ultrasonography in monitoring long-standing rheumatoid arthritis: a pilot study. Reumatologia 2017; 55: 177-182, DOI: 10.5114/reum.2017.69781.
34.
Pappas DA, Saunders KC, Etzel CJ, et al. Evaluation of the use of ultrasound to manage patients with rheumatoid arthritis over time: results from the Corrona registry. Ann Rheum Dis 2018; 77: 906-907.
35.
Paulshus Sundlisæter N, Aga AB, Olsen IC, et al. Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes. Ann Rheum Dis 2018; 77: 1421-1425, DOI: 10.1136/annrheumdis-2017-212830.
36.
Nordberg LB, Lillegraven S, Aga AB, et al. The impact of ultrasound on the use and efficacy of intraarticular glucocorticoid injections in early rheumatoid arthritis: secondary analyses from a randomized trial examining the benefit of ultrasound in a clinical tight control regimen. Arthritis Rheumatol 2018; 70: 1192-1199, DOI: 10.1002/art.40494.
37.
Naredo E, Valor L, De la Torre I, et al. Predictive value of doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis. Rheumatology (Oxford) 2015; 54: 1408-1414, DOI: 10.1093/rheumatology/kev006.
38.
Simpson E, Hock E, Stevenson M, et al. What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis. Health Technol Assess 2018; 22: 1-258, DOI: 10.3310/hta22200.
39.
de Miguel E, Pecondón-Español A, Castaño-Sánchez M, et al. A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis. Rheumatol Int. 2017; 37: 1347-1356, DOI: 10.1007/s00296-017-3714-5.
40.
Han J, Geng Y, Deng X, et al. Subclinical synovitis assessed by ultrasound predicts flare and progressive bone erosion in rheumatoid arthritis patients with clinical remission: a systematic review and metaanalysis. J Rheumatol 2016; 43: 2010-2018, DOI: 10.3899/jrheum.160193.
41.
Ponikowska M, Świerkot J, Nowak B. The importance of ultrasound examination in early arthritis. Reumatologia 2018; 56: 354-361, DOI: 10.5114/reum.2018.80712.
42.
Freeston JE, Wakefield RJ, Conaghan PG, et al. A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools. Ann Rheum Dis 2010; 69: 417-419, DOI: 10.1136/ard.2008.106658.
43.
Ten Cate DF, Luime JJ, Swen N, et al. Role of ultrasonography in diagnosing early rheumatoid arthritis and remission of rheumatoid arthritis – a systematic review of the literature. Arthritis Res Ther 2013; 15: R4, DOI: 10.1186/ar4132.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.